Overview
- 81 inspections across 79 sites are on record.
- 235 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-05-07.
At a glance
Inspections
81
Sites
79
Observations
235
Career since
Nov 2018
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Biofrontera Discovery GmbH | 7 May 2026 | Human Drugs | On file |
| Comparative Biosciences, Inc | 10 Apr 2026 | Human Drugs | On file |
| Naresh P. Singh, MD | 26 Mar 2026 | Human Drugs | On file |
| Ascendis Pharma LLC | 6 Mar 2026 | Human Drugs | On file |
| Yueming Song, MD | 6 Feb 2026 | Medical Devices & Rad Health | On file |
Sites inspected
Biofrontera Discovery GmbHLeverkusen, Germany1 insp.
Comparative Biosciences, IncSunnyvale, United States1 insp.
Naresh P. Singh, MDLas Vegas, United States1 insp.
Ascendis Pharma LLCPalo Alto, United States1 insp.
Yueming Song, MDChengdu, China1 insp.
Co-investigators
Investigators who share inspections with this person.
Kristin M Abaonza3 shared
Jeffrey P Raimondi3 shared
Dustin R Abaonza2 shared
Linda F Murphy2 shared
Andrew R Wasko1 shared
Melkamu Getie Kebtie1 shared
Humberto Z Gomez1 shared
Cynthia J Tsui1 shared
Stephanie Barragan1 shared
Joan T Briones1 shared
Full investigator report
Get the verbatim findings behind Scott N Lim's 235 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site